Information Provided By:
Fly News Breaks for August 8, 2018
BIOS
Aug 8, 2018 | 11:57 EDT
Barrington analyst Michael Petusky raised his price target for BioScrip to $4 from $3.50 citing the company's better than expected Q2 results. The analyst urges investors to consider the stock at current levels. The shares could "experience a true breakout over the next 12-18 months," Petusky tells investors in a research note. He thinks BioScrip has made a "significant amount" of operational progress throughout the past several quarters and that its turnaround plan is "largely being effectively executed." The analyst keeps an Outperform rating on the shares.
News For BIOS From the Last 2 Days
There are no results for your query BIOS